Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Buy
53
HNGE Quote, Financials, Valuation and Earnings
Last price:
$48.76
Seasonality move
:
--
Day range:
$47.48 - $49.03
52-week range:
$32.00 - $62.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.45x
P/B ratio:
18.41x
Volume:
798.1K
Avg. volume:
1.8M
1-year change:
--
Market cap:
$3.8B
Revenue:
$390.4M
EPS (TTM):
-$5.74
Analysts' Opinion
-
Consensus RatingHinge Health, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $64.29, Hinge Health, Inc. has an estimated upside of 32.17% from its current price of $48.76.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $48.00 representing 100% downside risk from its current price of $48.76.
Fair Value
-
According to the consensus of 8 analysts, Hinge Health, Inc. has 32.17% upside to fair value with a price target of $64.29 per share.
HNGE vs. S&P 500
-
Over the past 5 trading days, Hinge Health, Inc. has underperformed the S&P 500 by -2% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Hinge Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hinge Health, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Hinge Health, Inc. reported revenues of $154.2M.
Earnings Growth
-
Hinge Health, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Hinge Health, Inc. reported earnings per share of -$0.02.
Enterprise value:
3.6B
EV / Invested capital:
8.53x
Price / LTM sales:
7.45x
EV / EBIT:
--
EV / Revenue:
6.66x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
1,409.34x
Price / Operating cash flow:
1,517.70x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$420.3M
Return On Assets:
-60.19%
Net Income Margin (TTM):
-80.29%
Return On Equity:
-104.84%
Return On Invested Capital:
-102.33%
Operating Margin:
-3.19%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | $354.7M | $534.4M | $100.6M | $154.2M | |
| Gross Profit | $135.7M | $262.3M | $420.3M | $79.3M | $126.2M | |
| Operating Income | -- | -$74.6M | -$548.2M | -$3.9M | -$4.9M | |
| EBITDA | -- | -$74.2M | -$544.2M | -$3.8M | -$3.7M | |
| Diluted EPS | -$1.08 | -$0.81 | -$5.74 | $0.00 | -$0.02 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | $629.8M | |
| Total Assets | -- | -- | -- | -- | $769.8M | |
| Current Liabilities | -- | -- | -- | -- | $357.1M | |
| Total Liabilities | -- | -- | -- | -- | $361.9M | |
| Total Equity | -- | -- | -- | -- | $407.9M | |
| Total Debt | -- | -- | -- | -- | $4.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | $82.4M | |
| Cash From Investing | -- | -- | -- | -- | -$58.8M | |
| Cash From Financing | -- | -- | -- | -- | $531K | |
| Free Cash Flow | -- | -- | -- | -- | $81.3M | |
HNGE
Sector
Market Cap
$3.8B
--
Price % of 52-Week High
78.23%
--
Dividend Yield
0%
--
Shareholder Yield
-6.69%
--
1-Year Price Total Return
--
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$48.41
200-day SMA
Buy
Level
$0.00
Bollinger Bands (100)
Sell
Level
46.52 - 56.38
Chaikin Money Flow
Buy
Level
5M
20-day SMA
Buy
Level
$48.64
Relative Strength Index (RSI14)
Buy
Level
53.03
ADX Line
Buy
Level
10.52
Williams %R
Neutral
Level
-41.791
50-day SMA
Buy
Level
$47.74
MACD (12, 26)
Buy
Level
0.29
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
8.5M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Buy
CA Score
(Annual)
Level (0.2823)
Buy
Beneish M-Score
(Annual)
Level (-2.8961)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (3.7643)
--
Piotroski F Score
(Annual)
Level (--)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. It leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for its clients. The firm has designed its platform to address a broad spectrum of MSK care, ranging from acute injury, to chronic pain, to post-surgical rehabilitation, and the platform can help to ease members’ pain, improve their function, and reduce their need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere. The company was founded by Daniel Perez and Gabriel Mecklenburg in 2014 and is headquartered in San Francisco, CA.
Stock Forecast FAQ
In the current month, HNGE has received 7 Buy ratings 1 Hold ratings, and 0 Sell ratings. The HNGE average analyst price target in the past 3 months is $64.29.
-
Where Will Hinge Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hinge Health, Inc. share price will rise to $64.29 per share over the next 12 months.
-
What Do Analysts Say About Hinge Health, Inc.?
Analysts are divided on their view about Hinge Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hinge Health, Inc. is a Sell and believe this share price will drop from its current level to $48.00.
-
What Is Hinge Health, Inc.'s Price Target?
The price target for Hinge Health, Inc. over the next 1-year time period is forecast to be $64.29 according to 8 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is HNGE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hinge Health, Inc. is a Buy. 7 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HNGE?
You can purchase shares of Hinge Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hinge Health, Inc. shares.
-
What Is The Hinge Health, Inc. Share Price Today?
Hinge Health, Inc. was last trading at $48.76 per share. This represents the most recent stock quote for Hinge Health, Inc.. Yesterday, Hinge Health, Inc. closed at $48.76 per share.
-
How To Buy Hinge Health, Inc. Stock Online?
In order to purchase Hinge Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get HNGE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HNGE
Sector
P/E ratio
--
--
PEG ratio
-0.01x
--
P/B ratio
18.41x
--
Price / LTM sales
7.45x
--
Growth Metrics
HNGE
Sector
Revenue growth
53.27%
--
Earnings growth
-631.82%
--
Revenue (5-year growth)
--
--
Earnings forecast
$0.24
--
Profitability
HNGE
Sector
Profitability FY 2024
$300.6M
--
Return on invested capital
-102.33%
--
Return on assets
-60.19%
--
Return on equity
-104.84%
--
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
24
Estimated Next Earnings Date
Feb
3
Balance Sheet
HNGE
Sector
Total cash
$480M
--
Short term investments
$165.8M
--
Total assets
$675.5M
--
Long term debt
$4.9M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 23
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
